McDermott Will & Emery LLP and Bass, Berry & Sims PLC acted as legal advisors to WindRose and Kastner Gravelle LLP acted as legal advisor to...
Windrose Health Investors’ Acquisition of CardioOne
WindRose Health Investors’ $1.4 Billion Fund VI Formation
Weil advised WindRose on the fundraising. WindRose Health Investors announced the closing of its sixth fund, WindRose Health Investors VI, with more than $1.4 billion in...
WindRose Health Investors’ Investment in Third Wave Recovery Systems
McDermott Will & Emery represented WindRose, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo represented Third Wave in the transaction. WindRose Health Investors, LLC, a New...
RoslinCT’s Merger with Lykan Bioscience
Ropes & Gray and Slaughter & May acted as legal advisors to GHO, while McDermott Will & Emery LLP advised WindRose Health Investors, LLC. RoslinCT entered into...
WindRose’s Investment in RevHealth
McDermott Will & Emery LLP acted as legal advisor to WindRose, while DLA Piper LLP acted as legal advisor to RevHealth. WindRose Health Investors, LLC completed...
WindRose Health Investors’ Recapitalization of Veristat Group
McDermott Will & Emery represented WindRose Health Investors in the transaction. WindRose Health Investors, LLC, a healthcare focused private equity fund, completed its equity recapitalization of...